135 related articles for article (PubMed ID: 28261953)
1. Prognostic significance of CD133 and ezrin expression in colorectal carcinoma.
Fathi A; Mosaad H; Hussein S; Roshdy M; Ismail EI
IUBMB Life; 2017 May; 69(5):328-340. PubMed ID: 28261953
[TBL] [Abstract][Full Text] [Related]
2. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A
Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425
[TBL] [Abstract][Full Text] [Related]
5. CD 133+ and CXCR4+ colon cancer cells as a marker for lymph node metastasis.
Silinsky J; Grimes C; Driscoll T; Green H; Cordova J; Davis NK; Li L; Margolin DA
J Surg Res; 2013 Nov; 185(1):113-8. PubMed ID: 23777983
[TBL] [Abstract][Full Text] [Related]
6. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers.
Aikawa A; Fujita H; Kosaka T; Minato H; Kiyokawa E
Cancer Sci; 2019 Aug; 110(8):2667-2675. PubMed ID: 31175699
[TBL] [Abstract][Full Text] [Related]
9. CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer.
Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Peng Z; Hu J; Li Y; Mo X; Zhou Z
Oncotarget; 2016 Nov; 7(47):77389-77403. PubMed ID: 27764803
[TBL] [Abstract][Full Text] [Related]
10. CD133 Expression in Lymph Node Metastases Is Associated with Tumor Aggressiveness During Lymph Node Metastasis in Colorectal Cancer.
Kazama S; Kishikawa J; Yasuda K; Otani K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Yamaguchi H; Ishihara S; Sunami E; Watanabe T
Anticancer Res; 2015 Dec; 35(12):6599-605. PubMed ID: 26637875
[TBL] [Abstract][Full Text] [Related]
11. AC133 expression associated with poor prognosis in stage II colorectal cancer.
Ying X; Wu J; Meng X; Zuo Y; Xia Q; Chen J; Feng Y; Liu R; Li L; Huang W
Med Oncol; 2013 Mar; 30(1):356. PubMed ID: 23322518
[TBL] [Abstract][Full Text] [Related]
12. CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies.
Huang R; Mo D; Wu J; Ai H; Lu Y
Medicine (Baltimore); 2018 Jun; 97(23):e10446. PubMed ID: 29879012
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
Shen X; Bai Y; Luo B; Zhou X
Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
[TBL] [Abstract][Full Text] [Related]
14. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Study of Ezrin Expression in Colorectal Carcinoma: A Comparative Study between Objective Method and Digital Quantitative Assessment.
Ayad EE; Kamal Eldin YO; El-Hindawi AA; Abdelmagid MS; Elmeligy HA
Asian Pac J Cancer Prev; 2020 Apr; 21(4):967-974. PubMed ID: 32334457
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Expression of CD133 and LGR5 in Ulcerative Colitis-associated Colorectal Cancer and Dysplasia.
Kazama S; Kishikawa J; Tanaka T; Hata K; Kawai K; Nozawa H; Ishihara S
In Vivo; 2019; 33(4):1279-1284. PubMed ID: 31280219
[TBL] [Abstract][Full Text] [Related]
17. Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients.
Artells R; Moreno I; Díaz T; Martínez F; Gel B; Navarro A; Ibeas R; Moreno J; Monzó M
Eur J Cancer; 2010 Feb; 46(3):642-9. PubMed ID: 20005089
[TBL] [Abstract][Full Text] [Related]
18. Association between ezrin protein expression and the prognosis of colorectal adenocarcinoma.
Lin LJ; Chen LT
Mol Med Rep; 2013 Jul; 8(1):61-6. PubMed ID: 23708420
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery.
Nakamura K; Iinuma H; Aoyagi Y; Shibuya H; Watanabe T
Oncology; 2010; 78(5-6):309-15. PubMed ID: 20616575
[TBL] [Abstract][Full Text] [Related]
20. High expression of CD133 - stem cell marker for prediction of clinically agressive type of colorectal cancer.
Kostovski O; Antovic S; Trajkovski G; Kostovska I; Jovanovic R; Jankulovski N
Pol Przegl Chir; 2020 Apr; 92(3):9-14. PubMed ID: 32759397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
